Form 4: RxSight CFO Shelley Thunen Acquires 92,200 Stock Options

Shelley Thunen, CFO of RxSight, Inc., reports the acquisition of 92,200 stock options on March 4, 2024.

Summary

• On March 4, 2024, Shelley Thunen, the Chief Financial Officer of RxSight, Inc. (RXST), acquired 92,200 stock options.
• The exercise price of these options is $56.07.
• The options vest monthly over a four-year period, starting from March 4, 2024, contingent upon continued service as a Service Provider as defined in the Issuer's 2021 Equity Incentive Plan.
• The expiration date for these options is March 3, 2034.
• Following this transaction, Thunen directly owns 92,200 derivative securities.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral. It reflects standard insider activity.

Positives

• The acquisition of stock options by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of the stock options is contingent upon the Reporting Person continuing to be a Service Provider through each applicable date.

Industry Context

This is a standard SEC Form 4 filing, reporting a change in beneficial ownership by a company insider. Such filings are common and provide transparency into the trading activities of company executives.

Stakeholder Impact

• The acquisition of stock options by a key executive may signal confidence to shareholders.

Key Dates